These notes are for anyone considering posting a blog on BMJ EBM Spotlight, but especially for those with little or no previous experience of writing blogs. Carl Heneghan, Jeff Aronson Keep it simple Tackle only one problem or issue. Tell the reader why it is interesting and important. If it doesn’t interest YOU, write […]
40 years after its discovery, a re-analysis of the two largest trials to date, controversially suggests PSA screening may actually be beneficial. Jack O’Sullivan Most healthcare organisations do not recommend PSA screening for prostate cancer (USPSTF, Public Health England), mainly in response to conflicting evidence about the benefits and clear evidence of harms. PSA […]
The Better Evidence for Better Healthcare Manifesto (EBM manifesto) has been launched in order to improve the implementation of evidence-based interventions by pulling together a clear set of achievable goals and a strong overview of the strategies that work best, to help deliver change better and faster. In some areas, such as the treatment of illicit […]
CEBM deputy director Kamal R. Mahtani writes on the value of mentoring. There are times in our careers when we are not sure what to do next, whoever we are. We may lack experience or the confidence to decide what to do; or we may have made a decision and need a word of advice from someone […]
The global spend on biomedical research and development is about $250 billion, so why is so much of it still wasted, asks Kamal R. Mahtani. The global spend on biomedical research and development is estimated to be about $250 billion (£203 bn; €233 bn) each year—a not insignificant figure. In fact, it roughly equates to the amount that the UK […]